Tks5/Fish is a scaffolding protein with five SH3 domains and one PX domain. In Src-transformed cells, Tks5/Fish localizes to podosomes, discrete protrusions of the ventral membrane. We generated Src-transformed cells with reduced Tks5/ Fish levels. They no longer formed podosomes, did not degrade gelatin, and were poorly invasive. We detected Tks5/Fish expression in podosomes in invasive cancer cells, as well as in human breast cancer and melanoma samples. Tks5/Fish expression was also required for protease-driven matrigel invasion in human cancer cells. Finally, coexpression of Tks5/ Fish and Src in epithelial cells resulted in the appearance of podosomes. Thus, Tks5/Fish appears to be required for podosome formation, for degradation of the extracellular matrix, and for invasion of some cancer cells.
Introduction
vated forms of the protein tyrosine kinase Src has long provided a model for studying the properties of cancer cells (MarTo metastasize, tumor cells must invade into tissues and cross tin, 2001). Src-transformed cells are not only morphologically tissue boundaries. For most cancer cells, this is thought to retransformed, but are also highly invasive. They constitutively produce uPA and MMPs (Bell et al., 1990; Chen et al., 1991) . quire two events: increased motility, and proteolytic degradation of the extracellular matrix (Chang and Werb, 2001; They can degrade thin films of extracellular matrix proteins such as fibronectin, laminin, and collagen (Chen et al., 1984, and . The motility of cancer cells is driven by reorganization of the cytoskeleton and of contacts between the cell 1985). And they also are able to invade through matrigel (a mixture of basement membrane proteins) in a Boyden chamber and the matrix. This involves many of the same proteins that are required for normal cell motility, including members of the assay. How is the activation of these extracellular proteases coordinated? Many studies have implicated specialized strucRho family of small GTPases, and actin-associated proteins and regulators (Ridley et al., 2003) . Degradation of the extraceltures called podosomes, which are also often referred to as rosettes or invadopodia. Podosomes were first described as lular matrix occurs via the concerted action of a number of proteases, including matrix metalloproteases (MMPs), cathepelectron-dense protrusions of the ventral membrane of Srctransformed cells (David-Pfeuty and Singer, 1980 ; Tarone et al., sins, and serine proteases such as seprase and uPA (Chen, 1992; Bauvois, 2004) . The secretion of these proteases by tu-1985) . They were subsequently shown to have a diameter of approximately 0.4 m, to extend from the cell body into the mor cells results in the generation of "migration tracks" in the extracellular matrix, through which the cells can move. The relmatrix layer, to be enriched in actin, to be highly dynamic structures with a turnover time in the order of minutes, and to cluster evance of proteases to the invasive capacity of most tumor cells is supported by in vitro assays where invasion is blocked membrane proteases (Chen, 1989 (Chen, , 1990 . Following the discovery of podosomes in Src-transformed cells, similar strucby protease inhibitors, as well as in mouse model systems (Chang and Werb, 2001) .
tures were identified in osteoclasts, macrophages, and dendritic cells, all terminally differentiated cells of the monocyte The transformation of rodent and chicken fibroblasts by acti-lineage with the ability to cross tissue boundaries (Linder and Results Aepfelbacher, 2003; Buccione et al., 2004) . More recently, certain invasive human cancer cells, particularly breast cancers Reduction of Tks5/Fish expression in Src-transformed cells alters their morphology and melanomas, were also shown to contain podosomes Monsky et al., 1994; Bowden et al., 1999) . The cell
We utilized short hairpin (sh) RNA technology to reduce the level of Tks5/Fish in Src-transformed cells. We first tested the types in which podosomes are found support the notion that these structures are involved not just in cell motility, but also in ability of four short interfering (si) RNAs targeted to different regions of the Tks5/Fish gene to reduce expression of Tks5/ extracellular matrix degradation and invasiveness.
Podosomes are actin-rich structures, and contain many actin Fish in fibroblasts. Two of these siRNAs, 1 and 4, were effective (data not shown). We then went on to create shRNA expression regulatory proteins, such as WASp, Arp2/3, and the small G proteins cdc42 or RhoA, as well as actin-associated proteins vectors containing these sequences, transfected them into NIH3T3 (3T3) cells transformed with the activated cSrc allele such as gelsolin. Podosomes also contain proteins that are commonly found in focal adhesions, such as focal adhesion Y527F (Src3T3), selected several drug-resistant clones, and then tested for Tks5/Fish expression by immunoblotting. Only kinase (FAK), integrin receptors, paxillin, Src, and vinculin. However, other proteins found in podosomes are not found in shRNA sequence 4 efficiently reduced the expression of Tks5/ Fish when expressed in this hairpin vector rather than as a focal adhesions. These include the actin-associated protein cortactin, the GTPase dynamin, the proteases seprase and short RNA (data not shown). We chose three knockdown clones that had reduced Tks5/Fish expression (4.20, 4.21, and MT1-MMP (also known as MMP14), and the scaffolding protein Tks5/Fish (for review, see Linder and Aepfelbacher, 2003; Buc-4.24) , as well as three control clones that were drug selected after transfection with a vector containing a control sequence cione et al., 2004) . Several studies have shown that actin turnover is important in the formation of podosomes in various cell designed not to target murine sequences (C1, C2, and C3), for further analysis. Immunoblotting confirmed an approximately types. For example, WASp, Arp2/3, cdc42, RhoA, and gelsolin are all required for podosome formation, as is dynamin (Linder 5-fold reduction in Tks5/Fish levels in the knockdown, but not control, clones ( Figure 1A , top). An irrelevant protein of approxet al., 1999 Chellaiah et al., 2000a Chellaiah et al., , 2000b Ochoa et al., 2000; Mizutani et al., 2002; Moreau et al., 2003; Berdeaux et imately the same size (the PDGF receptor) was unaffected by the shRNA (data not shown), and all cells retained expression al., 2004). Furthermore, it was shown in a melanoma cell line that efficient extracellular matrix degradation required the poof the activated Src that was used to transform them ( Figure  1A , bottom). We also determined that the overall level of tyrodosomal localization of MT1-MMP (Nakahara et al., 1997) . The mechanisms by which podosome formation and function are sine phosphorylation was unchanged when compared to Src3T3 cells ( Figure 1B) , as was the ability of the cells to regulated are therefore of interest in the context of tumor metastasis.
secrete the metalloproteases MMP2 and MMP9 ( Figure 1C ). We noticed no obvious differences in the growth rates of the We recently used a novel Src substrate screening assay to isolate a new scaffolding protein with an aminoterminal phox control and knockdown clones (data not shown). Furthermore, the knockdown clones were still able to form foci when coculthomology (PX) domain, and five SH3 domains (Lock et al., 1998) . We originally called this protein Fish. However, because ured with normal fibroblasts, although we did notice that they displayed a fusiform morphology, rather than the more rounded of the difficulties associated with accessing the relevant literature and databases using the name Fish, we now propose to appearance of the control clones (data not shown). We next examined more closely the morphology of the revert to the original clone id name, Tks5. To avoid confusion during this transition, we will refer to the protein as Tks5/Fish knockdown and control clones, by plating them onto coverslips and visualizing F actin with fluorescent phalloidin (Figure throughout this manuscript.
We demonstrated that Tks5/Fish was cytoplasmic in normal 2A). The control clones retained the morphology of the parental Src3T3 cells, with few actin fibers and many podosomes. In fibroblasts, but was relocalized to podosomes in cells transformed by Src (Abram et al., 2003) . The PX domain of Tks5/ contrast, the knockdown clones were larger and flatter, with some actin stress fibers, but few obvious podosomes. The Fish is both necessary and sufficient for podosome localization. Like most, if not all, PX domains, the PX domain of Tks5/ morphological changes observed were present in essentially all cells in the population. Since only one of our shRNA vectors Fish associates with phosphatidylinositol lipids, with preference in vitro for PI 3-P and PI 3,4-P 2 . The podosomes of Srcefficiently reduced Tks5/Fish expression, we were concerned that the differences we observed might be due to off-target transformed cells are not enriched in PI 3-P (unpublished data), suggesting that PI 3,4-P 2 may be responsible for targeting effects of the interfering RNA. We therefore wanted to test whether the phenotypic differences observed could be reTks5/Fish to podosomes, but this remains to be established. The binding partners for most of the SH3 domains of Tks5/Fish versed by reintroduction of the Tks5/Fish protein. We took advantage of the fact that only 15 of the 19 base pairs encomare yet to be uncovered. However, we have shown that the 5 th SH3 domain associates with members of the ADAMs family of passing siRNA 4 are conserved in the human Tks5/Fish cDNA, and that, as determined by transfection, the levels of the humetalloproteases. Further analysis showed that as a consequence of this interaction, ADAM12, which is usually associman Tks5/Fish protein were unaffected by siRNA 4 (data not shown). We microinjected 4.20 cells with an expression vector ated with intracellular membranes in fibroblasts, is found in the podosomes of Src-transformed cells (Abram et al., 2003) .
containing a cDNA encoding human Tks5/Fish, incubated the cells for 24 hr, and then stained the cells with fluorescent phalWe hypothesized that Tks5/Fish might be involved in the formation and/or function of podosomes. Here, we describe the loidin and with an antibody that recognizes Tks5/Fish. We observed that all microinjected cells were replete with podoresults of experiments designed to test this hypothesis, in both Src-transformed fibroblasts and in human cancer cells.
somes, compared to the uninjected cells in the same field, which retained their more flattened morphology ( Figure 2B ). We therefore conclude that the Tks5/Fish protein is rate-limiting for the formation of podosomes in Src3T3 cells. We chose one knockdown (4.20) clone for further analysis, one representative cell is shown in Figure 2C . In the parental trast, podosomes were not observed in the 4.20 cells. Instead, Twenty-four hours later, the cells were fixed and stained with antibodies to actin stress fibers and cortical actin staining were observed.
Tks5/Fish to visualize the microinjected cells, and phalloidin to visualize F actin. Tks5/Fish staining is in red, and F actin staining in green.
Some of the peripheral actin appeared to be present in an "ar- adhesions in normal cells . We found that a proportion of these proteins were localized to podosomes in the parental cells, consistent with the reports of others (Linder and Aepfelbacher, 2003) . In contrast, in the 4.20 cells, these proSrc-transformed cells with reduced Tks5/Fish expression teins were localized to discrete spots in the periphery, coincishow defects in matrix degradation and invasion dent with the concentrations of F actin ( Figure 2C , and data
We next tested whether a reduction in the level of Tks5/Fish protein influenced the ability of the cells to degrade extracellunot shown), which may therefore represent focal adhesions. lar matrix proteins. To do this, we took advantage of an assay in which cells are plated onto fluorescently labeled matrix proteins (in this case FITC-gelatin), and degradation is assessed microscopically (Bowden et al., 2001) . In this assay, 3T3 cells do not degrade the gelatin, whereas the Src3T3 efficiently degrade the matrix layer in discrete spots coincident with the presence of podosomes, as described by others previously (data not shown). We observed that the control clones retained their ability to degrade gelatin, but the knockdown clones were unable to degrade the matrix protein efficiently during the course of this assay ( Figure 3A ). We next tested whether expression of human Tks5/Fish could rescue matrix degradation ( Figure 3B ). We found areas of degradation underneath the microinjected cells, but not around cells in another area of the coverslip that was not microinjected. We conclude therefore that matrix degradation requires Tks5/Fish.
In vitro, the invasive capacity of cells can be measured by testing their ability to invade through a layer of matrigel placed in a Boyden chamber. We next tested our clones in this assay ( Figure 3C ). Src-transformed cells are markedly more invasive than the parental fibroblasts from which they derive. All the control clones retained this degree of invasiveness. However, the Tks5/Fish knockdown clones behaved more like the 3T3 cells, and exhibited a marked reduction in invasive capacity. We also tested the motility of the knockdown clones ( Figure  3D ). Only one clone showed a statistically significant reduction in migration; the other two clones did not differ significantly from the parental cells or from the control clones. These data suggest that Tks5/Fish is not required for the enhanced motility of Src-transformed cells.
From these experiments, we conclude that Tks5/Fish is required for the formation of podosomes, as well as for matrix degradation and in vitro invasiveness. lines, particularly invasive breast carcinomas and melanomas, clones were tested over a period of 48 hr for the ability to degrade a thin and their presence has been correlated with invasiveness in layer of FITC-gelatin coated onto glass coverslips. Degradation is indicated by the dark patches (holes) within the fluorescent monolayer. Cell density vitro (Monsky et al., 1994; Kelly et al., 1998; Bowden et al., is indicated by Hoechst staining of nuclei (blue). Bt549 (Thompson et al., 1992; Bowden et al., 1999) . Tks5/Fish panel shows a region of the coverslip containing uninjected (uninj) cells.
Many human cancer cells express Tks5/Fish

1999). To determine whether
was expressed at very low levels in T47D and MCF7 cells, visi-C: 3T3 and Src3T3, along with control (C1, C2, and C3) and Tks5/Fish knockble only at longer exposures of the blot (data not shown), but down (4.20, 4.21, and 4.24) clones, were tested for their ability to invade through a thin layer of matrigel in a Boyden chamber assay over a period was more highly expressed in the invasive cells. All the melaof 24 hr. The data were compiled from three independent experiments. All noma cell lines we tested (including the RPMI-7951 and measurements were calculated as percent of control (Src3T3) and error C8161.9 lines used later, as well as several others, had Tks5/ bars calculated as propagated standard errors of the mean of triplicate Fish expression levels as high or higher than Bt549 cells; data measurements from each experiment. Statistical significance was deternot shown). As in fibroblasts, Tks5/Fish is expressed in multiple mined by paired t tests with an asterisk indicating a statistical difference from the control (p < 0.05).
forms in these cells; it is possible, but remains to be estab- we detected very low levels of mRNA in the T47D cells, but the MCF7 cells contained approximately the same level of mRNA as the invasive lines ( Figure 4B ), suggesting that Tks5/Fish expression is likely to be controlled at both the RNA and the protein level. A: Whole-cell lysates derived from the indicated breast carcinoma cell lines were normalized for protein concentration, then immunoprecipitated and immunoblotted with a Tks5/Fish antibody. Tks5/Fish is present as a closely spaced series of bands, present in different ratios depending on the cell line tested, as shown. B: RT-PCR was used to make a semiquantitative comparison of Tks5/Fish mRNA levels (upper band) across the indicated breast carcinoma cell lines. The lower band is nonspecific. C: Breast carcinoma cells were grown on glass coverslips for 48 hr, fixed, and stained with antibodies for Tks5/Fish, and phalloidin to visualize F actin, as shown. In each image, the localization of representative rosettes of podosomes is marked by arrowheads. We next determined whether Tks5/Fish was present in the podosomes of human cancer cells (Figures 4C and 4D ). We cancer ( Figure 5A ). We noted moderate Tks5/Fish expression should note that unlike Src-transformed fibroblasts, where pothat was restricted to ductal cells in normal breast tissue. Howdosomes are found in the majority of cells, in our hands, only ever, both ductal carcinoma in situ (DCIS) and metastatic a small percentage of the breast carcinoma and melanoma breast cancer samples showed extensive Tks5/Fish expression cells have podosomes at any given time. However, we did find in the malignant cells. No staining was observed with preimthat when we detected podosomes in both breast cancer cell mune rabbit serum as the primary, and a second Tks5/Fish lines (Bt549 and MDA-MB-231) and melanomas antibody that recognizes a different epitope gave the same and C8161.9), Tks5/Fish appeared to be colocalized to these staining pattern (data not shown). In total, we have analyzed structures, albeit it at very low levels.
14 samples of human breast tissue (4 normal, 3 DCIS, 3 microTo determine whether Tks5/Fish could also be detected in invasive, and 4 metastatic); all the precancerous and tumor human tumor samples, we first used immunohistochemistry to cells had higher Tks5/Fish staining than the surrounding normal tissue. We next went on to examine samples of skin tissue visualize Tks5/Fish in samples of normal breast and breast Two siRNAs (si1 and si2) targeting human Tks5/ Fish, or a pool of duplex controls (DC), were transiently transfected into BT549 breast carcinoma cells or RPMI-7951 melanoma cells. Thirty hours posttransfection, the cells were either processed for the measurement of Tks5/Fish protein levels following immunoprecipitation of lysates with a Tks5/Fish antibody (A), plated onto FITCgelatin coated glass coverslips to measure gelatin degradation activity (B), transferred to Boyden chambers to measure migration or invasion through matrigel (C), or quiesced for 48 hr in order to test the conditioned medium for gelatinase activity by zymography (D). The data in each panel derive from separate transfections, but in each case, immunoblotting was conducted to ensure that Tks5/Fish levels were reduced by the siRNA treatment. The data in C represent the mean of triplicate measurements (with propagated standard errors) expressed as a percentage of the duplex control treated cells from a single, representative experiment. Asterisks represent a statistical difference from the control (p < 0.05).
( Figure 5B ). We detected moderate Tks5/Fish staining in the Fish expression, no significant differences in MMP secretion were observed ( Figure 6D ). These data suggest that Tks5/Fish basal layer, but higher staining in both an early stage melanoma and a metastatic tumor. Interestingly, there was particuis also required for optimal matrix degradation and invasiveness of human cancer cells. larly intense staining in those melanoma cells that were invading into the surrounding tissue from the early stage melanoma It has recently been noted that cancer cells can penetrate extracellular matrix either in a manner that requires proteases, (middle panels). In total, we have analyzed 16 skin samples (4 normal, 7 with Breslow grading from 1-4 mm, and 4 metaor using a protease-independent mechanism that, in some cases at least, might be due to amoeboid-type movement (Sastatic), and have always observed higher Tks5/Fish staining in the tumors. We therefore conclude that Tks5/Fish is expressed hai and Marshall, 2003; Wolf et al., 2003) . To determine which mechanism might be in force in the cells we are studying, we in human tumor cells in vivo.
Tks5/Fish is required for invasion of human cancer cells
These findings prompted us to test whether Tks5/Fish was required for invasiveness in human cancer cells. We first chose one breast cancer cell line (Bt549) and one melanoma (RPMI-7951) for our analyses. We transfected them with two independent siRNAs targeting Tks5/Fish, or with a mixture of siRNAs designed to not reduce expression of cell proteins (duplex control). Reduction of all isoforms of Tks5/Fish with the specific siRNAs was confirmed by immunoblot analysis ( Figure 6A ). We next tested the ability of these cells to degrade thin films of gelatin ( Figure 6B ), and found that in both cases, the Tks5/Fish siRNA transfected cells showed reduced degradation compared to controls. We viewed at least 25 fields, and counted as positive all fields that contained any degradation, however small. For both cell lines, essentially all fields of duplex control transfected cells showed degradation. However, degradation was only observed in 55% or fewer of all fields of Tks5/Fish knockdown cells. Furthermore, even when degradation was observed, it was much less extensive in the Tks5/Fish knock- for RPMI-7951 in Figure 6B ). We next tested the invasiveness as described in Figure 6 , except that a cocktail of protease inhibitors (or of the siRNA-transfected cells in a Boyden chamber assay vehicle alone) were added to each experimental group of cells in order ( Figure 6C ). In each case, we noted a significant, but not absoto monitor the protease dependence of invasion through matrigel. The invasion of each experimental group of cells is expressed as a percentage lute, reduction in matrigel invasion in the cells with reduced of the duplex control-treated cells that lacked protease inhibitors in the Tks5/Fish expression. No significant differences in motility medium, and was analyzed as described in Figure 6 . siTks5 refers to the use were observed. We also found a similar requirement for Tks5/ of either siRNA2 alone (RPMI-7951; refer to Figure 6 ), a combination of Fish for invasiveness of the other tumor cell lines ( Figure 7 ). As siRNA1 and 2 (BT549, MB-231), or a pool of siRNAs (Hs578T, C8161.9). All of these conditions reduce Tks5/Fish protein levels.
was the case for the Src-transformed cells with reduced Tks5/ repeated the invasion experiments in the presence or absence is required for the formation of podosomes in Src-transformed cells. In the absence of robust Tks5/Fish expression, Src-transof a cocktail of protease inhibitors that have previously been shown to block proteolytic invasion (Sahai and Marshall, 2003) .
formed fibroblasts do not revert to an untransformed phenotype, but they do adopt a larger, flatter morphology, with some We found that whereas the invasion of the duplex controltreated cells could be partially blocked by the protease inhibinormal actin cytoskeleton. In addition, while the parental Srctransformed cells attach to the substratum via the podosomes, tors, little further reduction in invasion of the Tks5/Fish siRNA treated cells was detected in the presence of protease inhibithe knockdown cells have ventral structures that resemble focal adhesions, containing integrins, FAK, and vinculin ( Figure  tors (Figure 7 ). These data suggest that Tks5/Fish is required for the protease-driven invasion of matrigel.
2C and data not shown). This might suggest that, when present, the Tks5/Fish protein recruits focal adhesion proteins such as these, as well as cortical proteins such as cortactin, Expression of Tks5/Fish in T47D cells results in the generation of podosomes into the podosomes. Our data show that Tks5/Fish is required for podosome forOur studies to date have determined that the Tks5/Fish protein is required for the formation of podosomes. We next wanted mation. We also show that the introduction of Tks5/Fish (along with activated Src) results in the formation of podosomes in to determine whether introduction of Tks5/Fish into cells that do not normally express it was sufficient to drive podosome cells that do not normally have them. We have succeeded in generating podosomes in T47D cells (Figure 8 ), as well as formation. We chose T47D cells, which have very low levels of both Tks5/Fish mRNA and protein. When these cells were in-MCF7 and 293 cells (data not shown), all epithelial cells with a very low level of endogenous Tks5/Fish protein. We have prejected with an expression vector encoding Tks5/Fish, some morphological changes in the actin cytoskeleton were noted, viously shown that the PX domain of Tks5/Fish is required to target the protein to preformed podosomes in Src-transformed but no podosomes were observed (Figure 8 ). However, when Tks5/Fish was coinjected with an activated form of Src, punccells (Abram et al., 2003) . In keeping with this, a Tks5/Fish protein lacking the PX domain was unable to promote podosome tate actin-rich structures containing Tks5/Fish were evident on the ventral surface of the cell. No such structures were seen formation when coinjected with activated Src into T47D cells. The PX domain of Tks5/Fish is a phosphoinositide binding dowhen Src was expressed alone, although activated Src did have profound effects on both morphology and the actin cymain, with an apparent preference for PI3-P and PI3,4-P 2 . The model that we are currently testing is that Tks5/Fish is first toskeleton. Consistent with our previous findings that the PX domain of Tks5/Fish is required to target it to podosomes (Abrecruited diffusely to membranes via the interaction of its PX domain with a phosphatidylinositol lipid (perhaps PI3,4-P 2 ), ram et al., 2003), when Tks5/Fish⌬PX and Src were coexpressed, no podosomes were observed. Interestingly, in the and then a clustering of Tks5/Fish and its associated proteins results in the formation of podosomes. Perhaps one of the presence of Tks5/Fish⌬PX, expression of activated Src did not result in any gross morphological changes; rather, all actin pofunctions of activated Src in this assay is to (indirectly) generate the lipid product that recruits Tks5/Fish to the plasma lymerization in the cell appeared to be inhibited. We conclude that Tks5/Fish, when expressed in cells containing active Src, membrane. It is also possible that Tks5/Fish itself, as well as other podosome proteins, need to be tyrosine phosphorylated is able to promote the formation of podosomes.
for podosome formation. Indeed, it has been observed previously that podosomes are enriched in tyrosine phosphoryDiscussion lated proteins (Mueller et al., 1992) . The microinjection assay we describe here will now allow us to dissect the roles of Src, Tks5/Fish is a large adaptor protein and Src substrate that we have previously shown to be present in the podosomes of Srcand the different domains of Tks5/Fish, in podosome formation. Why is Tks5/Fish needed for podosome formation? One transformed cells (Abram et al., 2003) . We have now used shRNA technology to demonstrate that the Tks5/Fish protein model would be that it associates with, and thus recruits, pro-teins known to be required for podosome formation. In keeping were observed, we detected Tks5/Fish colocalization with the structures, suggesting that Tks5/Fish is a common component with this model, we have preliminary evidence that the 3 rd SH3 domain of Tks5/Fish is able to associate with the actin regulaof podosomes.
To determine whether Tks5/Fish is also required for the invatory protein N-WASp (unpublished data); N-WASp and the related protein WASp are essential for podosome formation in sive properties of human cancer cells, we used transient transfection of siRNAs, resulting in a reduction of Tks5/Fish expresSrc-transformed fibroblasts and macrophages, respectively Mizutani et al., 2002) .
sion of approximately 80%. We noticed a significant reduction in the ability of such cells to invade matrigel, compared to duAnalysis of Src-transformed cells with reduced Tks5/Fish expression revealed that they are markedly handicapped in both plex control cells. However, we noted that in each case, the inhibition was not complete. Furthermore, invasion of the conthe ability to degrade a thin film of gelatin, and in invasion through matrigel, both properties that are thought to involve trol cells was partially inhibited by treatment with a cocktail of protease inhibitors, whereas the Tks5/Fish knockdown cells proteases, particularly matrix metalloproteases. In this regard, it is interesting to note that the knockdown cells still secrete were not further inhibited by the addition of protease inhibitors to the assay. This suggests that some of the cells in the pop-MMP2 and MMP9, in both precursor and cleaved forms. At this point, it is not clear why these secreted MMPs are not able ulation can use a protease-independent method of invasion, as recently described. Interestingly, it has been shown that when to degrade the extracellular matrix. Perhaps they are required to be locally activated at podosomes to be functional. In keepproteolytic activity is inhibited, MDA-MB-231 cells use an amoeboid movement to penetrate matrigel . ing with this, the podosome localization of MT1-MMP, an activator of MMP2 and MMP9, appears to be required for matrix Our data support the hypothesis that Tks5/Fish is required for proteolytic invasion. It will be interesting to determine in the degradation (Nakahara et al., 1997) .
Epithelial cells typically express low levels of the Tks5/Fish future how many cancer cells use proteolytic mechanisms to invade, and whether such an invasive strategy correlates with protein. However, we have noted increased Tks5/Fish expression in many cancer cell lines, including invasive breast carcithe presence of podosomes in the cells.
In conclusion, we have shown that the adaptor protein and nomas ( Figure 4 ) and melanomas (data not shown). This finding was not restricted to cells in culture; we also noted marked Src substrate Tks5/Fish is required for podosome formation staining with Tks5/Fish antibodies in paraffin embedded tumor and function in Src-transformed fibroblasts. Furthermore, samples ( Figure 5 ). We are currently extending these analyses Tks5/Fish is overexpressed in some invasive human cancer to more cell lines and tissues, in order to address whether cells, and is required for proteolytic invasion. These findings Tks5/Fish levels may be predictive of invasive disease. This support a broader investigation of Tks5/Fish and its binding would be particularly useful in melanoma, where there are few proteins both as markers of invasive disease and as potential markers of metastatic disease. One breast cancer cell line with therapeutic targets. Finally, we have developed a method to low Tks5/Fish levels (T47D) has barely detectable Tks5/Fish form podosomes in cells that do not normally have them, mRNA, whereas the other (MCF7) has mRNA levels similar to which will allow us in the future to dissect the signals and prothose in the invasive lines. These findings suggest that Tks5/ teins that regulate podosome formation and turnover. Fish is regulated at both the RNA and the protein level, and
Experimental procedures
that microarray analysis will not always be suitable to measure Tks5/Fish levels in tumor samples. We have also observed that Constructs the half-life of the Tks5/Fish protein is considerably longer in
The mutant form of chicken Src with an activating Y527F substitution in Src-transformed cells than in their normal counterparts (unpubpSGT and the Tks5/Fish constructs have been previously described (Lock lished data), which might suggest that tyrosine phosphorylaet al., 1998; Abram et al., 2003) . All plasmids were double purified over tion, or podosomal localization, enhances its stability. More cesium chloride gradients.
work is clearly needed to determine how the level of the Tks5/
Cell lines
Fish protein is controlled.
NIH3T3 and SrcY527F-transformed NIH3T3 (Src3T3) cells have been deInvasive breast cancer cells and melanomas such as those scribed before (Lock et al., 1998) . The breast carcinoma cell lines  used in this study have been previously reported to have podoBt549, Hs578t, and MDA-MB-231 were generously provided by Dr. Han-Mo somes Monsky et al., 1994; Bowden et al., Koo, Van Andel Institute. The C8161.9 melanoma cell line was generously 1999). We have also observed podosomes in these cells, alprovided by Dr. Cindy Miranti, Van Andel Institute. T47D and RPMI-7951 though we find that in a given population of cells at a given cells were obtained from the ATCC. All cell lines were maintained in Dubecco's modified Eagle's medium (DMEM; Invitrogen) containing 10% fetal time, only the minority will have obvious podosomes. Perhaps calf serum (HyClone) and antibiotics in 10% CO 2 .
podosomes only form at a particular point in the cell cycle, or in response to a particular signal. This has previously been Biochemical techniques observed in cells of the macrophage/monocyte lineage. For exOur general procedures for cell lysis, immunoprecipitation, and immuample, podosomes form in osteoclasts as they differentiate noblotting have been described before, and are available on request. (Destaing et al., 2003) , and in dendritic cells as they initiate (Burns et al., 2004) . It is also known that podosomes have a generated by shRNA technology. Briefly, commercially synthesized complerapid turnover. In the future it will be important to determine mentary primers (Integrated DNA Technologies) were designed to express the signals that mediate the formation and turnover of podoa short hairpin (sh) RNA for the direct targeting and knockdown of murine somes of tumor cells; this control point might represent an Tks5/Fish mRNA sequences. These primers were annealed and the resultattractive target for therapeutic intervention. Regardless, in the ing construct ligated into pSilencer2.1U6hygro (Ambion) at the accessible BamHI/HindIII restriction sites using standard subcloning techniques. Sucinvasive breast cancer cells and melanomas where podosomes cessfully engineered plasmids were confirmed by restriction mapping and calf serum (FCS) placed in the insert chambers and with media containing 10% FCS in the lower chambers. Cells to be tested were detached from by DNA sequencing in the presence of 5% DMSO. Two different shRNAexpression constructs were tested based on previous success with the cultures dishes in trypsin/EDTA (Invitrogen). This reaction was stopped by a 2-fold dilution in 1 mg/ml soybean trypsin inhibitor/PBS (final concentraknockdown of Tks5/Fish in cells transiently transfected with siRNA sequences. A control shRNA sequence (C) was also designed because it does tion). Cells were sedimented at 1000 g for 5 min, suspended in 5 ml PBS, resedimented, and finally suspended in 1 ml of the appropriate growth menot target murine mRNAs (Ambion). The sequences are:
1: GATCCCGAACGAAAGCGGCTGGTGGTTCAAGAGACCACCAGCCGC dia containing 0.1% FCS. 25,000 cells (counted by automation; Beckman) in 500 l of media containing 0.1% FCS were placed into each Boyden TTTCGTTCTTTTTTGGAAA 4: GATCCCGCCAGTCCAACATCTCCTTCTTCAAGAGAGAAGGAGATGTT chamber. The appropriate growth media containing 10% FCS (750 l) was placed in the lower chamber to facilitate chemotaxis. Invasion assays were GGACTGGTTTTTTGGAAA C: GATCCCACTACCGTTGTTATAGGTGTTCAAGAGACACCTATAACAACG run for 24 (for Src-transformed fibroblasts) or 48 hr (for human cancer cell GTAGTTTTTTTGGAAA lines). Noninvading cells were removed from the insert chambers using cotThe complementary primer sequences are not shown; the siRNA seton swabs, then cells which passed through the matrigel membrane were quences are underlined. shRNA-expression plasmids were introduced into stained with 0.09% crystal violet/10% ethanol. After removing excess stain Src-transformed NIH3T3 cells using calcium phosphate. Drug-resistant colby washing with deionized water, the stain was eluted with 200 l of elution onies were selected in the presence of 100 g/ml hygromycin (Invitrogen) buffer (1 part acetate buffer [pH 4.5] : 2 parts ethanol : 1 part deionized water). supplemented into the culture medium. Drug-resistant cell lines were mainThe optical density of 100 l of the eluted stain was measured at 570 nm tained in 100 g/ml hygromycin, except during experimentation.
(96-well plate reader, Dynex Technologies). All assays were conducted in triplicate. To study the effect of protease inhibitors on cell invasion, 25,000 Transient Tks5/Fish knockdown experiments cells were suspended in 500 l of appropriate media containing 0.1% FCS Breast carcinoma and melanoma cells were grown to 70% confluency unand a cocktail of protease inhibitors, and were placed into each Boyden der standard growth conditions. Cells were washed into fresh culture mechamber. The inhibitor cocktail consists of 10 mM calpeptin (03-34-0051; dium 1 hr prior to transfections and into Opti-MEM (Invitrogen) 30 min prior Calbiochem), 20 mM GM6001 (364205; Calbiochem), 10 mg/ml aprotinin to transfections. Two duplex siRNAs (sense strands: GCCAAAGCAAGGAC (616370; Calbiochem), and 10 mg/ml leupeptin (108975; Calbiochem). Ap-GAGAU [si1] and AAACCAGUGGCGACCUGAA [si2]) directed against hupropriate media (750 l) containing 10% FCS and the same inhibitor cockman Tks5/Fish (Dharmacon) were used either alone or in combination to tail was placed in the lower chamber. Measurement of invasion was done knockdown Tks/Fish protein. A "Smartpool" of four siRNAs (Dharmacon) as described above. Motility assays were conducted in Boyden transwell was also used to knockdown human Tks/Fish protein (none of these siRNAs chambers lacking matrigel over a period of 24 hr. Experimental conditions have the same sequence as si1 and si2 above). siRNAs were combined and the processing of chambers were as described above. with Lipofectamine 2000 (Invitrogen) according to manufacturer's guidelines and added to cells in Opti-MEM at a final concentration of 100 nM. Control Microinjection transfections consisted of a pool of four nontargeting siRNAs (duplex conCells were grown to 50%-60% confluency on etched CellLocate glass covtrol, Dharmacon). Transfections were carried out for 3 hr at 37°C, after which erslips (Eppendorf). All injected DNA samples were adjusted to 100 g/ml, the transfection medium was replaced with fresh culture medium. Analysis except where indicated in the figure legend. DNA samples were microinof Tks5/Fish protein levels, podosome formation, and transfer into invasion jected into the nuclei of attached cells using either custom-pulled micropiassays were initiated 30 hr posttransfection.
pette needles (Flaming/Brown micropipette puller, Sutter Instrument) or prepulled Femtotips needles (Eppendorf). Standardized injection parameters Fluorescence microscopy were programmed into a Femtojet Micromanipulator 5171 (Brinkmann) acCells were grown for a minimum of 48 hr postpassage on glass coverslips.
cording to manufacturer's guidelines and visualized with an Axiovert 200 Cells were fixed in 3% formaldehyde (Electron Microscopy Sciences)/PBS inverted fluorescent microscope (Zeiss). To assay podosomes, the cells for 10 min, made permeable in 0.1% Triton X-100/PBS for 10 min, and were incubated 24 hr after injection and processed by standard fluoresprocessed with various antibody applications and/or phalloidin in 5% doncence microscopy procedures. key serum (Jackson Immuno-Research Laboratories)/PBS. Primary detection reagents include antibodies for Tks5/Fish (Tks5/Fish.2 1736, 1:500), Histochemistry Src (327), β1-integrin (N-20, 1:400; Santa Cruz), FAK (2A7, 1:200; Upstate Slides containing thin sections of dewaxed human breast or skin tissue Biotechnology), and F actin (Alexa Fluor 488 and 594 phalloidin, 1:1000;
were warmed in Coplin jars containing 10 mM sodium citrate (pH 6.5) for Molecular Probes). Secondary detection reagents include Alexa Fluor 488 20 min at 90°C before being allowed to cool back to room temperature. and 594-and Texas Red-conjugated IgGs (1:2000; Molecular Probes). After
With interspersed washes in PBS, all samples were prepped for antibody washing extensively in PBS, coverslips were mounted in 1 mg/ml p-phenylapplication by successive 30 min treatments in 0.1% Triton-X 100/PBS, 3% ene diamine (Sigma) in 90% glycerol/PBS. Images were captured using an hydrogen peroxide, and 1% BSA/5% donkey serum/PBS. With interAxioplan 2 fluorescent microscope and were analyzed with Axiovision 3.0 spersed washes in PBS, Tks5/Fish detection was procured using a polysoftware (Zeiss).
clonal antibody to the first SH3 domain of Tks5/Fish (D7771) at 1:100 dilution in 5% donkey serum/PBS for overnight at 4°C, a biotinylated anti-rabbit ECM degradation assay secondary antibody (Santa Cruz) at 1:100 dilution in 5% donkey serum/ Fluorescein isothiocyanate (FITC)-labeled gelatin-coated coverslips were PBS for 1 hr at room temperature, and an HRP-conjugated anti-biotin tertiprepared essentially as described before (Bowden et al., 2001 ) with some ary antibody (Vectastain, Vector Laboratories) used according to manufacmodifications. Briefly, 2% gelatin (300 bloom; Sigma)/2% sucrose/PBS was turer guidelines. Slides were developed using 3,3# diaminobenzidine as prelabeled with 0.2 mg/ml FITC (Fluka) in 50 mM sodium borate (Sigma), substrate (DAB Substrate Kit, Vector Laboratories) according to manufac-40 mM sodium chloride (Sigma) (pH 9.3) before dialysis into PBS. A thin turer's guidelines. Alternatively, slides were stained with hematoxylin and layer of FITC-gelatin was coated onto glass coverslips and immediately eosin. Images were obtained using an Eclipse E600 bright field microscope crosslinked with ice-cold 0.8% glutaraldehyde (Electron Microscopy Sci-(Nikon) and were digitally captured using Spot Advanced 4.0.4 software ences)/PBS for 15 min at 4°C and then for 30 min at room temperature.
(Diagnostics Instruments). Coverslips were successively washed in PBS (3 × 5 min), 5 mg/ml sodium borate/PBS (1 × 3 min), PBS (3 × 5 min), and 70% ethanol (1 × 10 min), Zymography before quenching for 1 hr with DMEM. Cells were cultured such that by 100,000 cells (counted by automation; Beckman) in 2 ml of DMEM contain-48 hr the coverslips were nearly confluent. Coverslips were subsequently ing 10% FCS were placed in single wells of a 6-well dish and grown to 80% processed using standard fluorescence microscopy procedures.
confluency. Cells were washed 2 times in 2 ml PBS and then incubated with 2 ml Opti-MEM for 48 hr. Conditioned medium was collected from the Motility and Invasion assays cells, filtered at 0.2 m, and diluted with zymogram sample buffer (BioMatrigel-containing Boyden transwell chambers (BD Biosciences) were prehydrated 6 hr prior to cell application with medium containing 0.1% fetal Rad). Samples were analyzed on 10% acrylamide/gelatin Criterion gels
